Rosa Cámara

848 total citations
34 papers, 391 citations indexed

About

Rosa Cámara is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Rosa Cámara has authored 34 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 6 papers in Genetics. Recurrent topics in Rosa Cámara's work include Pituitary Gland Disorders and Treatments (20 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Adrenal and Paraganglionic Tumors (11 papers). Rosa Cámara is often cited by papers focused on Pituitary Gland Disorders and Treatments (20 papers), Growth Hormone and Insulin-like Growth Factors (14 papers) and Adrenal and Paraganglionic Tumors (11 papers). Rosa Cámara collaborates with scholars based in Spain, Palestinian Territory and United States. Rosa Cámara's co-authors include Antonio Picó, Carmen Fajardo, Cristina Lamas, Araceli García‐Martínez, Ignacio Aranda, Amparo Vayá, Ignacio Bernabéu, Antonio Hernández‐Mijares, Eva Solá and Marco Romagnoli and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology.

In The Last Decade

Rosa Cámara

33 papers receiving 385 citations

Peers

Rosa Cámara

EDM

SURGE

GENET

EPIDE

PRM

Mark Gruppetta Malta

Diane Donegan United States

Fabienne Langlois Canada

Nigel Glynn Ireland

Shahla Nader United States

Dima Abdelmannan United States

Betina Biagetti Spain

I. Raingeard France

M. J. THOMSETT Australia

P. Chanson France

Mark Gruppetta Malta

Rosa Cámara

280 ×1.1

EDM

152 ×1.0

SURGE

66 ×0.8

GENET

78 ×0.9

EPIDE

27 ×0.8

PRM

Citations per year, relative to Rosa Cámara Rosa Cámara (= 1×) peers Mark Gruppetta

Countries citing papers authored by Rosa Cámara

Since Specialization

Citations

This map shows the geographic impact of Rosa Cámara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Cámara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Cámara more than expected).

Fields of papers citing papers by Rosa Cámara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Cámara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Cámara. The network helps show where Rosa Cámara may publish in the future.

Co-authorship network of co-authors of Rosa Cámara

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Cámara. A scholar is included among the top collaborators of Rosa Cámara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Cámara. Rosa Cámara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Araujo‐Castro, Marta, Javier Aller, Mónica Marazuela, et al.. (2025). Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinología Diabetes y Nutrición. 72(10). 501654–501654. 1 indexed citations

Lamas, Cristina, Rosa Cámara, Carmen Fajardo, et al.. (2023). Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain. Frontiers in Endocrinology. 14. 1204206–1204206. 7 indexed citations

Gil, Joan, Elena Valassi, Araceli García‐Martínez, et al.. (2022). Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 10(2). 460–460. 9 indexed citations

Puig‐Domingo, Manel, Ignacio Bernabéu, Antonio Picó, et al.. (2021). Pasireotide in the Personalized Treatment of Acromegaly. Frontiers in Endocrinology. 12. 648411–648411. 29 indexed citations

García‐Martínez, Araceli, Rosa Cámara, Carmen Fajardo, et al.. (2021). The silent variants of pituitary tumors: demographic, radiological and molecular characteristics. Journal of Endocrinological Investigation. 44(8). 1637–1648. 6 indexed citations

García‐Martínez, Araceli, et al.. (2020). Is Somatostatin Receptor and Dopamine Receptor profiling useful in the management of silent somatotroph tumors?. Journal of Endocrinological Investigation. 43(6). 859–863. 4 indexed citations

García‐Martínez, Araceli, Rosa Cámara, Carmen Fajardo, et al.. (2019). How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?. Cancers. 11(12). 1990–1990. 16 indexed citations

Lamas, Cristina, et al.. (2019). Silent somatotropinomas. PubMed. 44(2). 137–142. 8 indexed citations

Cámara, Rosa, Eva Venegas, Juan Antonio García-Arnés, et al.. (2019). Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study. Pituitary. 22(2). 137–145. 9 indexed citations

10.

Bernabéu, Ignacio, Rosa Cámara, Mónica Marazuela, & Manel Puig‐Domingo. (2018). Documento de expertos sobre el manejo de la acromegalia. Endocrinología Diabetes y Nutrición. 65(8). 428–437. 1 indexed citations

11.

García‐Martínez, Araceli, Carmen Fajardo, Pedro Riesgo, et al.. (2018). Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?. PLoS ONE. 13(7). e0198877–e0198877. 15 indexed citations

12.

Sánchez-Tejada, Laura, Cristina Lamas, Rosa Cámara, et al.. (2017). Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas. PLoS ONE. 12(7). e0180039–e0180039. 17 indexed citations

13.

Alba, A. Budía, et al.. (2016). Papel del IGF-1 y la distribución de la grasa corporal para disminuir el número de rebiopsias prostáticas. Actas Urológicas Españolas. 41(2). 82–87. 1 indexed citations

14.

Sesmilo, Gemma, Eugenia Resmini, Ignacio Bernabéu, et al.. (2014). Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre S panish study. Clinical Endocrinology. 81(6). 883–890. 17 indexed citations

15.

Vayá, Amparo, Rafael Alis, Antonio Hernández‐Mijares, et al.. (2014). Red blood cell distribution width is not related with inflammatory parameters in morbidly obese patients. Clinical Biochemistry. 47(6). 464–466. 18 indexed citations

16.

Sierra, Pilar, et al.. (2014). ¿Cuál es la relevancia real y el manejo de las principales alteraciones tiroideas en los pacientes bipolares?. Revista de Psiquiatría y Salud Mental. 7(2). 88–95. 14 indexed citations

17.

Sierra, Pilar, et al.. (2014). What is the real significance and management of major thyroid disorders in bipolar patients?. Revista de Psiquiatría y Salud Mental (English Edition). 7(2). 88–95. 11 indexed citations

18.

Sesmilo, Gemma, Sonia Gaztambide, Eva Venegas, et al.. (2012). Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary. 16(1). 115–121. 55 indexed citations

19.

Cámara, Rosa, et al.. (2007). Severe hypoglycemia after gastric bypass surgery for morbid obesity. Diabetes Research and Clinical Practice. 79(1). e7–e9. 29 indexed citations

20.

Estrada, Javier Solis, et al.. (1987). [Pituitary function in craniopharyngioma: study of 8 cases before and after treatment].. PubMed. 180(4). 194–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact